stockrowNano-X Imaging Ltd.
NNOX Healthcare Medical Devices
Nano-X Imaging Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $13.0 million, up 15.4% from fiscal 2024.
- Revenue
- +36.7%
- EPS
- −243.5%
- Free cash flow
- −21.4%
- Total debt
- −12.0%
Quarter to June 2026, against a year earlier
Follow NNOX
Alert me
Nano-X Imaging Ltd. (NNOX) EV/Sales
As of 6 November 2026, Nano-X Imaging Ltd. (NNOX) trades at a EV/Sales of −0.5×. Over the past ten years it has ranged from −0.5× (November 2026) to 121× (June 2023) — the current reading is the lowest in ten years. That is below the Medical Devices industry median of 2.8× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 10.7× | (67.61%) |
| FY2024 | 32.9× | 12.92% |
| FY2023 | 29.1× | (16.43%) |
| FY2022 | 34.9× | — |
| FY2021 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 3.6× | (56.57%) |
| Mar 2026 | 8.3× | (22.10%) |
| Dec 2025 | 10.7× | (34.25%) |
| Sep 2025 | 16.2× | (32.44%) |
| 15 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| NNOX Nano-X Imaging Ltd. | −0.5× |
| RBOT Vicarious Surgical Inc. compare | n/m |
| ARAY Accuray Incorporated compare | 0.2× |
| SNWV Sanuwave Health Inc. compare | 0.7× |
| CTSO Cytosorbents Corporation compare | 0.7× |
| LFWD Lifeward Ltd. compare | 0.8× |
| PMI Flag Ship Acquisition Corp compare | 2.8× |
| ALUR Allurion Technologies, Inc. compare | 5.3× |
| HSCS HeartSciences Inc. compare | 519× |
| Medical Devices industry median | 2.8× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)